# PillPack

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/pillpack

- Industry: Retail
- Headquarters: Manchester, US
- Website: www.pillpack.com/
- Total disclosed funding: $94M
- Latest round: Series C (Aug 22, 2016)
- Investors on record: 18

## About

PillPack LLC, based in the US, operates a pharmacy service that simplifies medication management through the organization and delivery of medications in pre-sorted packets tailored to customer needs.PillPack LLC is a pharmacy service that organizes and delivers medications directly to consumers. Founded in 2013 in Manchester, US, PillPack was acquired by Amazon.com, Inc. in June 2018 for USD 753 mn, enhancing Amazon's healthcare offerings. The company was co-founded by Elliot Cohen, who has a background in pharmacy and healthcare services. PillPack has successfully completed 5 deals since its inception, with its most recent deal occurring in June 2018.PillPack, operated by Amazon Pharmacy, offers a comprehensive pharmacy service aimed at simplifying medication management for its customers. The core service revolves around organizing and delivering medications in pre-sorted packets, tailored to the user's specific scheduling needs. This service is designed to alleviate the complexities associated with managing multiple prescriptions, ensuring that users receive their medications on time, every month. PillPack’s customer base primarily includes individuals who require regular medication, particularly the elderly and those with chronic conditions, who benefit from streamlined access to their pharmaceuticals without the need for frequent pharmacy visits. The service operates across various geographical markets within the United States, providing access to a wide demographic that includes both consumers and healthcare providers who seek to enhance patient adherence to prescribed therapies.PillPack operates under a revenue model primarily based on the sale of medications, as users pay for their prescriptions while receiving expert pharmacy services at no additional charge. The company facilitates transactions through direct-to-consumer sales, allowing customers to order their medications via online platforms or through consultations with pharmacy advisors. This streamlined approach includes automatic refill management, where PillPack monitors prescriptions in collaboration with healthcare providers to ensure continuous medication supply. Revenue is generated as customers utilize PillPack's services, with the firm serving as an intermediary between the patients and their healthcare plans.Following its acquisition by Amazon.com, Inc. in June 2018, PillPack plans to leverage its resources to further integrate into Amazon's broader healthcare strategy, enhancing medication delivery systems. The funding from the acquisition will support the expansion of PillPack's pharmacy services and improve customer convenience, especially for those managing multiple prescriptions. Specific plans include developing new services aimed at improving patient adherence and exploring expansion into additional geographic markets, although such markets have not yet been detailed.

## Funding rounds

- Series C, Aug 22, 2016, $31M — Accel, CRV, Menlo Ventures, Entree Capital, Founders Circle Capital, ACME Capital, Accomplice, Astral Capital Partners, Cherry Tree Investments
- Series C, May 22, 2015, $50M — Accel, Atlas Venture, CRV, Menlo Ventures, Entree Capital, ACME Capital, Accomplice, Cherry Tree Investments
- Series B, Oct 9, 2014, $8.8M — Accel, Atlas Venture, High Line Venture Partners, Slow, Queensbridge Venture Partners, Third Kind Venture Capital
- Series A, Feb 4, 2014, $4M — Atlas Venture, Founder Collective, TechStars, IDEO, Techstars, BoxGroup

## Investors

- Atlas Venture (https://capitalatlas.ai/funds/atlas-venture) — Series A, Series B, Series C
- Founder Collective (https://capitalatlas.ai/funds/founder-collective) — Series A
- TechStars (https://capitalatlas.ai/funds/techstars) — Series A
- IDEO — Series A
- BoxGroup (https://capitalatlas.ai/funds/boxgroup) — Series A
- Accel (https://capitalatlas.ai/funds/accel) — Series B, Series C
- High Line Venture Partners (https://capitalatlas.ai/funds/high-line-venture-partners) — Series B
- Slow (https://capitalatlas.ai/funds/slow) — Series B
- Queensbridge Venture Partners (https://capitalatlas.ai/funds/queensbridge-venture-partners) — Series B
- Third Kind Venture Capital (https://capitalatlas.ai/funds/third-kind-venture-capital) — Series B
- CRV (https://capitalatlas.ai/funds/crv) — Series C
- Menlo Ventures (https://capitalatlas.ai/funds/menlo-ventures) — Series C
- Entree Capital (https://capitalatlas.ai/funds/entree-capital) — Series C
- ACME Capital (https://capitalatlas.ai/funds/acme-capital) — Series C
- Accomplice (https://capitalatlas.ai/funds/accomplice) — Series C
- Cherry Tree Investments — Series C
- Founders Circle Capital (https://capitalatlas.ai/funds/founders-circle-capital) — Series C
- Astral Capital Partners (https://capitalatlas.ai/funds/astral-capital-partners) — Series C